+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Glaucoma Surgery Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5176821
  • Report
  • August 2020
  • Region: Global
  • 117 Pages
  • Mordor Intelligence


  • Abbott Laboratories Inc
  • Alcon
  • Allergan
  • Carl Zeiss Meditec
  • Glaukos Corporation
The Glaucoma Surgery Devices Market is expected to register a CAGR of 6.5% during the forecast period. This is attributing to the rising prevalence of glaucoma, increasing geriatric population, growing adoption of surgical treatments for glaucoma. In addition, the rising demand for minimally invasive procedures associated with glaucoma is also expected to trigger the growth of the market. These procedures give benefits like reduced surgery time, faster recovery, affordability, and low risk of complications, thus driving the market. As per the report published by the American Academy of Ophthalmology (AAO), the global prevalence of glaucoma was estimated to 64.3 in 2013 and expected to reach 76 million by 2020. Furthermore, favorable reimbursements policies, rising government initiatives, and improvement in healthcare around developing countries are also expected to boost the glaucoma surgery devices market.

Key Market Trends

Minimal Invasive Glaucoma Surgery by Surgery Type is Estimated to Witness a Healthy Growth in Future.

The minimal invasive glaucoma surgery is expected to witness healthy growth in the future, which is attributed to an increasing number of cataract surgeries and glaucoma surgeries. These devices are extensively used in the surgeries due to their long procedural volume. Moreover, product approvals associated with glaucoma surgery devices are also expected to boost the segment growth. Glaukos Corporation received FDA approval for iStent, a type of minimally invasive glaucoma surgery drainage device used in cataract surgeries. In addition, another company Ivantis also received approval for Hydrus Microstent (MIGS device) I 2018. These devices are efficient in glaucoma surgeries thus results in propelling the segment growth

In addition, the increasing number of glaucoma patients across the world is leading to a high demand for glaucoma surgery devices and thus propelling the overall market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a significant market share in the global Glaucoma Surgery Devices Market due to the increasing prevalence of glaucoma, rising geriatric population, increasing awareness, favorable reimbursements policies, and the presence of several major players. As per a report published by Glaucoma Research Foundation in 2018, an estimate of 3 million people has glaucoma, and the number will be going to increase in the coming years. Moreover, the growing number of geriatric populations in the United States is more prone to have glaucoma. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Glaucoma Surgery Devices Market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Abbott Laboratories Inc, Lumenis, Alcon, Glaukos Corporation, ASICO, LLC., Katalyst Surgical LLC, Allergan, Ziemer Ophthalmic Systems, and Carl Zeiss Meditec.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • Abbott Laboratories Inc
  • Alcon
  • Allergan
  • Carl Zeiss Meditec
  • Glaukos Corporation

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Glaucoma
4.2.2 Increasing Geriatric Population
4.2.3 Growing Adoption of Surgical Treatments for Glaucoma
4.3 Market Restraints
4.3.1 Availability of Alternative Treatment Methods
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Glaucoma Drainage Device
5.1.2 Laser system
5.1.3 Punches
5.1.4 Probes
5.1.5 Others
5.2 By Surgery Method
5.2.1 Traditional glaucoma surgery
5.2.2 Minimal invasive glaucoma surgery
5.2.3 Laser Surgery
5.3 By End User
5.3.1 Hospitals
5.3.2 Ophtalmic Clinics
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Abbott Laboratories Inc
6.1.2 Lumenis
6.1.3 Alcon
6.1.4 Glaukos Corporation
6.1.6 Katalyst Surgical LLC
6.1.7 Allergan
6.1.8 Ziemer Ophthalmic Systems
6.1.9 Carl Zeiss Meditec
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc
  • Lumenis
  • Alcon
  • Glaukos Corporation
  • Katalyst Surgical LLC
  • Allergan
  • Ziemer Ophthalmic Systems
  • Carl Zeiss Meditec
Note: Product cover images may vary from those shown